September 02, 2014
September 01, 2014
August 31, 2014
CMS’ Proposed Rule Delays ICD-10 Deadline to October 2014
April 9, 2012, the Centers for Medicare & Medicaid Services (CMS) announced a proposed rule that delays the ICD-10 compliance deadline one year, to October 1, 2014. The proposed rule also adopts a standard for a unique health plan identifier (HPID), adopts a data element that would serve as an “other entity” identifier (OEID), and adds a National Provider Identifier (NPI) requirement.
According to CMS, the introduction of the HPID under HIPAA standards for electronic health care transactions will provide increased standardization for providers who currently face improper routing, rejected transactions, difficulty in determining eligibility, and errors in identifying the correct health plan during claims processing. CMS reports that the HPID will allow for a higher level of provider automation without the use of multiple identifiers that differ in length and format.
The proposed rule adopts a data element to serve as the OEID for entities that are not health plans, health care providers, or “individuals” that need to be identified in standard transactions (e.g., third party administrators, transaction vendors, clearinghouses, and other payers). The proposed rule does not require such entities to obtain an OEID, but the entities may obtain and use an OEID in covered transactions. However, once an OEID is obtained, entities would be expected to use the OEID and disclose it upon request when engaged in covered transactions.
The proposed rule also outlines circumstances under which an organization covered health care provider must require noncovered individual health care providers who are prescribers to obtain and disclose a NPI. Organization covered health care providers that have as a member, employ, or contract with, an individual health care provider who is not a covered entity and is a prescriber must require such a prescriber to: (1) obtain an NPI, and (2) to the extent the prescriber writes a prescription while acting within the scope of the prescriber’s relationship with the organization, disclose the NPI upon request to any entity that needs it to identify the prescriber in a standard transaction.
<span class="advertise"> Advertisement </span>
- EU Court Of Justice Further Clarifies Definition Of Medicinal Products – And Raises New Questions
- China Issues Multiple Final Rules and Proposals to Implement Recent Revisions to its Core Medical Device Regulation
- Summary of FDA Advertising and Promotion Enforcement Activities – September 2, 2014
- The Increasingly Murky World of 340B Drug Discount Program: What’s Next?
- EEOC Sues Arthur’s Restaurant & Bar for Pregnancy Discrimination
- Physician Compensation under Medicaid